Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 5, 2025Journal of Comparative Effectiveness ResearchOpen Access

Evaluation of the treatment patterns among commercially insured patients with nonvalvular atrial fibrillation prescribed an oral anticoagulant by race/ethnicity

View Full Paper
Ask AI
Bookmark
Share

Authors

MZM ZhangRSRisho SinghSDS. Dhuliawala

Discussion

Loading...

Member takes

Overview

Retrospective study shows treatment patterns for oral anticoagulants varied by race/ethnicity, highlighting disparities in discontinuation rates.

Key Points

  • Apixaban users exhibited a 24% lower likelihood of treatment discontinuation compared to warfarin patients.
  • Higher discontinuation rates were noted among Black patients (68%) compared to White (60%) and Hispanic (63%).
  • Almost 5% of apixaban patients switched to another oral anticoagulant, in contrast to 31% on warfarin.
  • The findings underscore racial differences in treatment patterns for oral anticoagulants, warranting further research.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/689521f09f4f1c896c428775https://doi.org/10.57264/cer-2025-0057
View Full Paper
Ask AI
Bookmark
Share